CD34 is a well-known marker of angiogenesis and endothelial progenitor cells (21, 22), whilst VWF is a multimeric plasma glycoprotein that mediates platelet adhesion to both the subendothelial matrix and endothelial surfaces (23) and is associated with tumor survival and angiogenesis (24, 25). Here, VWF is linked to neoplasm.